GC
GMT Capital Portfolio holdings
AUM
$2.39B
This Quarter Return
-5.03%
1 Year Return
+35.72%
3 Year Return
+134.93%
5 Year Return
+289.6%
10 Year Return
+622.15%
AUM
$2.66B
AUM Growth
+$2.66B
(+0.48%)
Cap. Flow
+$199M
Cap. Flow
% of AUM
7.5%
Top 10 Holdings %
Top 10 Hldgs %
53.68%
Holding
110
New
16
Increased
24
Reduced
13
Closed
2
Top Buys
| 1 |
Bath & Body Works
BBWI
|
$52.9M |
| 2 |
iShares Semiconductor ETF
SOXX
|
$37.1M |
| 3 |
Royalty Pharma
RPRX
|
$25.2M |
| 4 |
TSMC
TSM
|
$21M |
| 5 |
Hudbay
HBM
|
$19.9M |
Top Sells
| 1 |
PVH
PVH
|
$33M |
| 2 |
TD Synnex
SNX
|
$26.2M |
| 3 |
B2Gold
BTG
|
$19.6M |
| 4 |
iShares China Large-Cap ETF
FXI
|
$16.7M |
| 5 |
Comerica
CMA
|
$14.6M |
Sector Composition
| 1 | Consumer Discretionary | 24.6% |
| 2 | Materials | 23.02% |
| 3 | Industrials | 18% |
| 4 | Technology | 10.22% |
| 5 | Communication Services | 8.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Royalty Pharma
RPRX
$15.8B
| $25.2M | 0.95% |
+929,700
| New | +$25.2M |
|
27
Freshpet
FRPT
$2.59B
| $18.7M | 0.7% |
283,800
| – | – |
|
28
Warner Bros
WBD
$29.5B
| $17.4M | 0.65% |
1,598,700
+819,169
| +105% | +$8.9M |
|
29
Gran Tierra Energy
GTE
$143M
| $17.3M | 0.65% |
2,488,831
| – | – |
|
30
Garrett Motion
GTX
$2.61B
| $16.9M | 0.64% |
+2,145,882
| New | +$16.9M |
|
31
Palantir
PLTR
$367B
| $16.3M | 0.61% |
1,017,400
| – | – |
|
32
Kyndryl
KD
$7.4B
| $14.6M | 0.55% |
+964,700
| New | +$14.6M |
|
|
MRNS
33
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $13.9M | 0.52% |
1,722,695
+167,700
| +11% | +$1.35M |
|
34
NewAmsterdam Pharma
NAMS
$2.8B
| $12.8M | 0.48% |
1,383,800
| – | – |
|
35
Meta Platforms (Facebook)
META
$1.85T
| $11.7M | 0.44% |
39,000
-27,200
| -41% | -$8.17M |
|
36
Fastly
FSLY
$1.08B
| $11.5M | 0.43% |
598,800
| – | – |
|
|
37
B2Gold
BTG
$5.45B
| $10.9M | 0.41% |
3,775,494
-6,790,600
| -64% | -$19.6M |
|
|
NKLA
38
DELISTED
Nikola Corporation Common Stock
NKLA
| $10.6M | 0.4% |
6,732,133
| – | – |
|
39
Amylyx Pharmaceuticals
AMLX
$877M
| $10.6M | 0.4% |
576,300
+115,300
| +25% | +$2.11M |
|
|
40
PVH
PVH
$4.1B
| $10.3M | 0.39% |
135,100
-431,700
| -76% | -$33M |
|
41
Microchip Technology
MCHP
$34.2B
| $9.83M | 0.37% |
+126,000
| New | +$9.83M |
|
42
Abercrombie & Fitch
ANF
$4.35B
| $9.81M | 0.37% |
174,000
| – | – |
|
43
Ventyx Biosciences
VTYX
$184M
| $9.75M | 0.37% |
280,600
| – | – |
|
|
KLRS
44
Kalaris Therapeutics, Inc. Common Stock
KLRS
$85.5M
| $9.05M | 0.34% |
4,211,283
+107,204
| +3% | +$230K |
|
45
Rocket Pharmaceuticals
RCKT
$358M
| $8.43M | 0.32% |
411,200
-20,900
| -5% | -$428K |
|
46
Kiniksa Pharmaceuticals
KNSA
$2.63B
| $8.3M | 0.31% |
477,853
+178,609
| +60% | +$3.1M |
|
47
Annexon
ANNX
$225M
| $6.63M | 0.25% |
2,810,471
+345,900
| +14% | +$816K |
|
48
Nutrien
NTR
$27.6B
| $6.22M | 0.23% |
+100,700
| New | +$6.22M |
|
49
Okta
OKTA
$15.8B
| $5.95M | 0.22% |
73,000
| – | – |
|
50
Outset Medical
OM
$245M
| $5.88M | 0.22% |
+540,776
| New | +$5.88M |
|